AO
Artivion, Inc.
AORT · NYSE
$25.13 -1.72% (-$0.44)
1M -4.48%
Market Cap $1.22B
P/E Ratio -
Div. Yield -
ROE 0.71%
Bulios Fair Price
$22.17
11.8% downside
Current Price
$25.13
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AORT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
30 /100
Expensive P/S 2.59x
P/B 2.74x
EV/EBITDA 27.01x
Growth
81 /100
Growing Book val. growth 16.38%
Rev. growth 12.04%
FCF growth N/A
Profitability
26 /100
Weak FCF margin 2.31%
Op. margin 4.00%
Gross margin 62.80%
Quality
6 /100
Poor Asset turnover 0.44x
ROA 0.30%
ROIC 2.75%
Debt
34 /100
Moderate Net debt/EBITDA 5.76x
Int. coverage 1.09x
Debt/Equity 0.92x
Stability
47 /100
Moderate Profitable years 1
EPS volatility 110.95%
Beta 1.25x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AORT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
James Patrick Mackin
Employees
1,800
Headquarters
Kennesaw
Upcoming events
05 NOV
Earnings
Upcoming earnings report